Trial Details

COMPLETED
Basic Information
Clinical ID c4380
Identifier NCT00603733
Trial Title Canadian Active & Maintenance Modified Pentasa Study
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Active Ulcerative Colitis|Remission of Ulcerative Colitis
Interventions DRUG: 5-ASA (5-Aminosalicylate)|DRUG: 5-ASA (5-Aminosalicylate)
Participant Information
Sponsor Ferring Pharmaceuticals
City Alberta
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2007-10
Primary Completion Date 2011-05
Completion Date 2011-05